Adaptin Bio, Inc.
APTN
OTC PK
Recommendation
Dividend Power Score
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -13.59% | -24.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.36% | 10.17% | |||
| Operating Income | 18.36% | -10.17% | |||
| Income Before Tax | 18.36% | -10.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 18.36% | -10.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 18.36% | -10.17% | |||
| EBIT | 18.36% | -10.17% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 18.62% | -10.17% | |||
| Normalized Basic EPS | 18.64% | -10.23% | |||
| EPS Diluted | 19.05% | -11.11% | |||
| Normalized Diluted EPS | 18.64% | -10.23% | |||
| Average Basic Shares Outstanding | 0.32% | 0.01% | |||
| Average Diluted Shares Outstanding | 0.32% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||